A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

Nature

Volumn 445, Issue 7123, 2007, Pages 106-110

  O'Brien, Catherine A ^a   Pollett, Aaron ^b   Gallinger, Steven ^b   Dick, John E ^a,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN;

CANCER; DIGESTIVE SYSTEM; GROWTH RATE; HIERARCHICAL SYSTEM; IMMUNOASSAY; RODENT; TRANSPLANTATION; TUMOR;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER STEM CELL; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL ISOLATION; CELL POPULATION; COLON CANCER; COLON CARCINOGENESIS; FEMALE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; KIDNEY CAPSULE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; TUMOR GROWTH; XENOGRAFT;

AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MIDDLE AGED; NEOPLASM TRANSPLANTATION; PEPTIDES; TRANSPLANTATION, HETEROLOGOUS; TUMOR STEM CELLS;

EID: 33846100356     PISSN: 00280836     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/nature05372     Document Type: Article

References (26)

1. Fearon, E. R. & Vogelstein, B. A genetic model for colorectal cancer tumorigenesis. Cell 61, 759-767 (1990).
2. Fearon, E. R. & Jones, P. A. Progressing toward a molecular description of colorectal cancer development. FASEB J. 6, 2783-2790 (1992).
3. Radtke, F. & Clevers, H. Self-renewal and cancer of the gut: two sides of a coin. Science 307, 1904-1909 (2005).
4. Nelson, H. et al. Guidelines 2000 for colon and rectal cancer surgery. J. Natl Cancer Inst. 93, 583-596 (2001).
5. O'Connell, J. B., Maggard, M. A. & Ko, C. Y. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J. Natl Cancer Inst. 96, 1420-1425 (2004).
6. Dick, J. E. Breast cancer stem cells revealed. Proc. Natl Acad. Sci. USA 100, 3547-3549 (2003).
7. Wang, J. C. & Dick, J. E. Cancer stem cells: lessons from leukemia. Trends Cell Biol. 15, 494-501 (2005).
8. Pocard, M., Tsukui, H., Salmon, R. J., Dutrillaux, B. & Poupon, M. F. Efficiency of orthotopic xenograft models forhumancolon cancers. In Vivo 10, 463-469 (1996).
9. Ravi, R. et al. Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL. Cancer Res. 64, 9105-9114 (2004).
10. Golas, J. M. et al. SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models. Cancer Res. 65, 5358-5364 (2005).
11. Sack, M. J. & Roberts, S. A. Cytokeratins 20 and 7 in the differential diagnosis of metastatic carcinoma in cytologic specimens. Diagn. Cytopathol. 16, 132-136 (1997).
12. Ishida, H. et al. Ki-67 and CEA expression as prognostic markers in Dukes' C colorectal cancer. Cancer Lett. 207, 109-115 (2004).
13. Liang, J. T. et al. Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer. Br. J. Surg. 91, 355-361 (2004).
14. Porter, E. H. & Berry, R. J. The efficient design of transplantable tumour assays. Br. J. Cancer 17, 583-595 (1964).
15. Wang, J. C., Doedens, M. & Dick, J. E. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 89, 3919-3924 (1997).
16. Al Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983-3988 (2003).
17. Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396-401 (2004).
18. Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105-111 (2001).
19. Marzesco, A. M. et al. Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J. Cell Sci. 118, 2849-2858 (2005).
20. Corbeil, D. et al. The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J. Biol. Chem. 275, 5512-5520 (2000).
21. Madlambayan, G. J. et al. Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion. Exp. Hematol. 33, 1229-1239 (2005).
22. Lapidot, T. et al. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 367, 645-648 (1994).
23. Hope, K. J., Jin, L. & Dick, J. E. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nature Immunol. 5, 738-743 (2004).
24. Al Hajj, M. & Clarke, M. F. Self-renewal and solid tumor stem cells. Oncogene 23, 7274-7282 (2004).
25. Polyak, K. & Hahn, W. C. Roots and stems: stem cells in cancer. Nature Med. 12, 296-300 (2006).
26. Al Hajj, M., Becker, M. W., Wicha, M., Weissman, I. & Clarke, M. F. Therapeutic implications of cancer stem cells. Curr. Opin. Genet. Dev. 14, 43-47 (2004).